Home › NDC Lookup › RxCUI directory › RxCUI 198075

Perphenazine 16 MG Oral Tablet — RxCUI 198075

RxNorm drug concept · Semantic clinical drug
RxCUI 198075 Semantic clinical drug · SCD ● Current RxNorm concept 49 FDA products 105 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198075
Official namePerphenazine 16 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped49
Package NDCs mapped105
Reported Medicaid activity (SDUD)66,408 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Perphenazine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats schizophrenia and controls severe nausea and vomiting in adults. Your prescriber chose it for one of those reasons. It is not approved for dementia-related psychosis.
  • Take the tablets by mouth exactly as your prescriber directs. Your dose is adjusted to your response, with the goal of using the lowest dose that works. If it is dosed at bedtime,...
  • Drowsiness, dizziness when standing, dry mouth, constipation and blurry vision are common, and drowsiness often eases after a week or two. Call your doctor for muscle spasms, restl...
  • What side effects are normal, and which ones should I call about?
📖 Read our full Perphenazine guide →

🕸️ Concept Web — How Perphenazine 16 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Perphenazine 16 MG Oral Tablet RxCUI 198075

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Perphenazine 8076
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Perphenazine Oral Tablet 373299
    • Perphenazine Oral Product 1165436
    • Perphenazine Pill 1165437
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Perphenazine 16 MG 316468

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Perphenazine 16 MG SCDC · 316468
  • Perphenazine Oral Tablet SCDF · 373299
  • Perphenazine Oral Product SCDG · 1165436
  • Perphenazine Pill SCDG · 1165437

📦 FDA Products & Package NDCs

49 products · 105 package NDCs
105 package NDCs map to RxCUI 198075 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-4101-01 100 TABLET, FILM COATED in 1 BOTTLE (0591-4101-01) Perphenazine Actavis Pharma, Inc. 2017-05-30
00591-4102-01 100 TABLET, FILM COATED in 1 BOTTLE (0591-4102-01) Perphenazine Actavis Pharma, Inc. 2017-05-30
00591-4103-01 100 TABLET, FILM COATED in 1 BOTTLE (0591-4103-01) Perphenazine Actavis Pharma, Inc. 2017-05-30
00591-4104-01 100 TABLET, FILM COATED in 1 BOTTLE (0591-4104-01) Perphenazine Actavis Pharma, Inc. 2017-05-30
00603-5060-21 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5060-21) Perphenazine Endo USA, Inc. 1998-12-31
00603-5061-21 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5061-21) Perphenazine Endo USA, Inc. 1998-12-31
00603-5061-28 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5061-28) Perphenazine Endo USA, Inc. 1998-12-31
00603-5062-21 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5062-21) Perphenazine Endo USA, Inc. 1998-12-31
00603-5062-28 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5062-28) Perphenazine Endo USA, Inc. 1998-12-31
00603-5063-21 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5063-21) Perphenazine Endo USA, Inc. 1998-12-31
00781-8046-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-8046-01) Perphenazine Sandoz Inc 2018-08-28
00781-8047-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-8047-01) Perphenazine Sandoz Inc 2018-08-28
00781-8048-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-8048-01) Perphenazine Sandoz Inc 2018-08-28
00781-8049-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-8049-01) Perphenazine Sandoz Inc 2018-08-28
23155-0799-01 100 TABLET in 1 BOTTLE (23155-799-01) PERPHENAZINE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2022-10-01
23155-0800-01 100 TABLET in 1 BOTTLE (23155-800-01) PERPHENAZINE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2022-10-01
23155-0801-01 100 TABLET in 1 BOTTLE (23155-801-01) PERPHENAZINE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2022-10-01
23155-0802-01 100 TABLET in 1 BOTTLE (23155-802-01) PERPHENAZINE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2022-10-01
33342-0448-11 100 TABLET in 1 BOTTLE (33342-448-11) Perphenazine Macleods Pharmaceuticals Limited 2024-05-06
33342-0448-15 500 TABLET in 1 BOTTLE (33342-448-15) Perphenazine Macleods Pharmaceuticals Limited 2024-05-06
33342-0449-11 100 TABLET in 1 BOTTLE (33342-449-11) Perphenazine Macleods Pharmaceuticals Limited 2024-05-06
33342-0449-15 500 TABLET in 1 BOTTLE (33342-449-15) Perphenazine Macleods Pharmaceuticals Limited 2024-05-06
33342-0450-11 100 TABLET in 1 BOTTLE (33342-450-11) Perphenazine Macleods Pharmaceuticals Limited 2024-05-06
33342-0450-15 500 TABLET in 1 BOTTLE (33342-450-15) Perphenazine Macleods Pharmaceuticals Limited 2024-05-06
33342-0451-11 100 TABLET in 1 BOTTLE (33342-451-11) Perphenazine Macleods Pharmaceuticals Limited 2024-05-06
33342-0451-15 500 TABLET in 1 BOTTLE (33342-451-15) Perphenazine Macleods Pharmaceuticals Limited 2024-05-06
51407-0694-01 100 TABLET in 1 BOTTLE (51407-694-01) perphenazine Golden State Medical Supply, Inc. 2022-12-21
51407-0695-01 100 TABLET in 1 BOTTLE (51407-695-01) perphenazine Golden State Medical Supply, Inc. 2022-12-21
51407-0696-01 100 TABLET in 1 BOTTLE (51407-696-01) perphenazine Golden State Medical Supply, Inc. 2022-12-21
51407-0697-01 100 TABLET in 1 BOTTLE (51407-697-01) perphenazine Golden State Medical Supply, Inc. 2022-12-21
52536-0162-01 100 TABLET, FILM COATED in 1 BOTTLE (52536-162-01) Perphenazine Wilshire Pharmaceuticals, Inc. 2018-02-06
52536-0164-01 100 TABLET, FILM COATED in 1 BOTTLE (52536-164-01) Perphenazine Wilshire Pharmaceuticals, Inc. 2018-02-06
52536-0168-01 100 TABLET, FILM COATED in 1 BOTTLE (52536-168-01) Perphenazine Wilshire Pharmaceuticals, Inc. 2018-02-06
52536-0170-01 100 TABLET, FILM COATED in 1 BOTTLE (52536-170-01) Perphenazine Wilshire Pharmaceuticals, Inc. 2018-02-06
63629-2248-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63629-2248-1) Perphenazine Bryant Ranch Prepack 2021-07-16
64980-0290-01 100 TABLET, FILM COATED in 1 BOTTLE (64980-290-01) PERPHENAZINE Rising Pharma Holdings, Inc. 2019-03-01
64980-0291-01 100 TABLET, FILM COATED in 1 BOTTLE (64980-291-01) PERPHENAZINE Rising Pharma Holdings, Inc. 2019-03-01
64980-0292-01 100 TABLET, FILM COATED in 1 BOTTLE (64980-292-01) PERPHENAZINE Rising Pharma Holdings, Inc. 2019-03-01
64980-0293-01 100 TABLET, FILM COATED in 1 BOTTLE (64980-293-01) PERPHENAZINE Rising Pharma Holdings, Inc. 2019-03-01
68382-0591-01 100 TABLET in 1 BOTTLE (68382-591-01) perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0591-05 500 TABLET in 1 BOTTLE (68382-591-05) perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0591-30 10 BLISTER PACK in 1 CARTON (68382-591-30) / 10 TABLET in 1... perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0592-01 100 TABLET in 1 BOTTLE (68382-592-01) perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0592-05 500 TABLET in 1 BOTTLE (68382-592-05) perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0592-30 10 BLISTER PACK in 1 CARTON (68382-592-30) / 10 TABLET in 1... perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0593-01 100 TABLET in 1 BOTTLE (68382-593-01) perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0593-05 500 TABLET in 1 BOTTLE (68382-593-05) perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0593-30 10 BLISTER PACK in 1 CARTON (68382-593-30) / 10 TABLET in 1... perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0594-01 100 TABLET in 1 BOTTLE (68382-594-01) perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
68382-0594-05 500 TABLET in 1 BOTTLE (68382-594-05) perphenazine Zydus Pharmaceuticals (USA) Inc. 2020-07-16
Observed labelers: Proficient Rx LP (36) · Zydus Lifesciences Limited (12) · Zydus Pharmaceuticals (USA) Inc. (12) · Macleods Pharmaceuticals Limited (8) · Endo USA, Inc. (6) · Actavis Pharma, Inc. (4) · +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.